We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.52B
1-Year Est. Return 36.54%
This Fund
S&P 500
This Quarter Est. Return
-0.28%
1 Year Est. Return
+36.54%
3 Year Est. Return
+184.84%
5 Year Est. Return
+166.78%
10 Year Est. Return
+454.52%
AUM
$415M
AUM Growth
+$53.2M
Cap. Flow
+$18.1M
Cap. Flow %
4.36%
Top 10 Hldgs %
51.96%
Holding
55
New
14
Increased
13
Reduced
3
Closed
13

Top Buys

Rank Stock Value
1
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$19.4M
2
AT
Atlantic Power Corporation
AT
+$13.6M
3
ECHO
EchoStar
ECHO
+$11.8M
4
NFX
Newfield Exploration
NFX
+$11.7M
5
TLM
TALISMAN ENERGY INC
TLM
+$11.1M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$19.3M
2
CRZO
Carrizo Oil & Gas Inc
CRZO
+$18.6M
3
NSM
Nationstar Mortgage Holdings
NSM
+$18.6M
4
FUR
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
+$13.8M
5
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$12.3M

Sector Composition

Rank Sector Weight
1 Real Estate 25.37%
2 Financials 22.94%
3 Miscellaneous 19.16%
4 Energy 8%
5 Utilities 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FUR
51
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
– –
-883,014
Closed -$13.8M
COV
52
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-120,000
Closed -$12.3M
AGN
53
DELISTED
Allergan Inc
AGN
– –
-90,702
Closed -$19.3M
1 2
3

Similar funds

ACM
Atika Capital Management New York $1.52B AUM 229.41% 1-Year Est. Return
ACM
Adelante Capital Management Alameda, California $1.52B AUM 23.15% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.52B AUM 47.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.52B AUM 10.48% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return

Mangrove Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Mangrove Partners held 55 positions worth $415M, up 15% from $362M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Mangrove Partners deployed $18.1M of net new capital in Q1 2015, opening 14 new positions and adding to 13 existing holdings. Its largest new stake was Eiger BioPharmaceuticals, Inc.: 2,222 shares worth $18.9M.

By sector, the portfolio is most concentrated in Real Estate at 25% of assets, down from 30% a quarter earlier, followed by Financials and Miscellaneous.

On the sell side, the largest reduction was Ready Capital, an estimated $1.43M trimmed.

  • Mangrove Partners's largest Q1 2015 buy was Eiger BioPharmaceuticals, Inc.: 2,222 shares worth $18.9M.
  • Mangrove Partners added most to Atlantic Power Corporation in Q1 2015, an estimated $13.6M increase.
  • Mangrove Partners's biggest Q1 2015 reduction was Ready Capital, cutting an estimated $1.43M.
  • Mangrove Partners fully exited Allergan Inc in Q1 2015, selling an estimated $19.3M.
  • Mangrove Partners's ten largest holdings make up 52% of its $415M portfolio in Q1 2015.
  • Mangrove Partners opened 14 new positions and closed 13 in Q1 2015.
  • Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $415M.

Based on Mangrove Partners's 13F filing for Q1 2015, filed 15 May 2015.